GlassScriptPhysician profile
Michael A Goodier
NPI 1023239134
$2,474.09
in general payments reported to CMS, 2019-2025
19 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $142 · 2021: $54.36 · 2022: $367 · 2023: $329 · 2024: $594 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.40 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $803.29 | 2019-2024 | Acclarent Aera, Spine & Trauma 3d Navigation |
| Genzyme Corporation | $326.49 | 2023-2025 | |
| Optinose US, INC. | $313.66 | 2019-2025 | |
| Glaxosmithkline, LLC. | $302.96 | 2023-2025 | Nucala |
| Medtronic, INC. | $167.88 | 2023-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform, Propel |
| Abbvie INC. | $112.96 | 2022 | |
| Alk-Abello, INC | $72.89 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $46.86 | 2024 | Dupixent |
| Janssen Pharmaceuticals, INC | $45.90 | 2022 | |
| Hikma Pharmaceuticals USA | $41.89 | 2024-2025 | Ryaltris |
| Stryker Corporation | $41.09 | 2019-2023 | Audion Et Dilation System |
| Hill Dermaceuticals, INC. | $38.46 | 2023-2024 | Tolak |
| Amgen INC. | $34.00 | 2025 | |
| Urovant Sciences INC | $31.62 | 2021 | |
| Abbott Laboratories | $30.85 | 2023 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $22.91 | 2019 | |
| Novo Nordisk INC | $13.95 | 2022 | |
| Aerin Medical INC. | $13.56 | 2019 | |
| Intersect Ent, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goodier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.